SlideShare a Scribd company logo
1 of 38
Cervical dysplasia
…………………………………
Definition
O Cervical dysplasia refers to the presence
of precancerous changes of the cells that
make up the inner lining of the cervix, the
opening to the womb (uterus).
O The term dysplasia refers to the abnormal
appearance of the cells when viewed
under the microscope. The degree and
extent of abnormality seen on a tissue
sample (such as a Pap smear) was
formerly referred to as mild, moderate, or
severe dysplasia.
The 2 new systems for studying the cervical dysplasia :.
O (cytological system ): Squamous
intraepithelial lesion is the pathology
terminology for cervical dysplasia observed in
smears of cells taken from the cervix.
Squamous refers to the type of cell that lines
the cervix. intraepithelial refers to the fact that
these cells are present in the lining tissue of
the cervix.
O (histological system ): Cervical intraepithelial
neoplasia is cervical dysplasia that is
observed on a cervical biopsy or surgically
removed cervix.
Cervical intraepithelial
neoplasia
The causes :
O Cervical dysplasia is caused by infection of the cervix
with the human papillomavirus (HPV). Although there
are over 100 HPV types, a subgroup of HPVs have been
found to infect the lining cells of the genital and
reproductive tract in women. HPV is a very common
infection and is transmitted through sexual contact; , it is
possible to become re-infected with a different HPV
type.
O Factors that may influence persistence of the infection
include:
O advancing age,
O duration of the infection, being infected with a "high-
risk" HPV type).
O Among the HPVs that infect the genital tract,
certain types typically cause warts or mild
dysplasia ("low-risk" types; HPV-6, HPV-11),
while other types (known as "high-risk" HPV
types) are more strongly associated with
severe dysplasia and cervical cancer (HPV-
16, HPV-18). Cigarette smoking and
suppression of the immune system (such as
with concurrent HIV infection) have been
shown to increase the risk for HPV-induced
dysplasia and cancer of the cervix.
O The HPV types that cause cervical cancer
also have been linked with both anal and
penile cancer in men as well as a subgroup of
head and neck cancers in both women and
men.
Risk factor :
O In women, an increased risk of a
persistent HPV infection is associated
with:
O Early initiation of sexual activity.
O Having multiple sex partners.
O Having a partner who has had multiple
sex partners.
O Having sex with an uncircumcised man.
Signs or symptoms :
O Typically, cervical dysplasia does not
produce any signs or symptoms. So
regular screening is important for early
diagnosis and treatmen
Diagnosis
O Because a pelvic exam is usually normal in women with cervical dysplasia, a
Pap test is necessary to diagnose the condition.
O Although a Pap test alone can identify mild, moderate, or severe cervical
dysplasia, further tests are often required to determine appropriate follow-up
and treatment. These include:
O Repeat Pap tests.
O Colposcopy, a magnified exam of the cervix to detect abnormal cells so that
biopsies can be taken.
O Endocervical curettage, a procedure to check for abnormal cells in the
cervical canal.
O Cone biopsy or loop electrosurgical excision procedure (LEEP), which are
performed to rule out invasive cancer. During a cone biopsy, the doctor
removes a cone-shaped piece of tissue for lab examination. During LEEP, the
doctor cuts out abnormal tissue with a thin, low-voltage electrified wire loop.
O HPV DNA test, which can identify the HPV strains which are known to
cause cervical cancer.
Classification / cytologic
O Cytological analysis : by pap smear
O ASC-US: This abbreviation stands for atypical squamous cells of
undetermined significance. The word "squamous" describes the thin, flat
cells that lie on the surface of the cervix. One of two choices are added
at the end of ASC: ASC-US, which means undetermined significance, or
ASC-H, which means cannot exclude HSIL
.
O LSIL: This abbreviation stands for low-grade squamous intraepithelial
lesion. This means changes characteristic of mild dysplasia are observed
in the cervical cells.
O HSIL: This abbreviation stands for high-grade squamous intraepithelial
lesion. And refers to the fact that cells with a severe degree of dysplasia
are seen.
Classification / histological
O Histologic analysis (cervical biopsies):
O CIN 1 refers to the presence of dysplasia confined to the
basal third of the cervical lining, or epithelium (formerly
called mild dysplasia). This is considered to be a low-grade
lesion.
O CIN 2 is considered to be a high-grade lesion. It refers to
dysplastic cellular changes confined to the basal two-thirds
of the lining tissue (formerly called moderate dysplasia).
O CIN 3 is also a high grade lesion. It refers to
precancerous changes in the cells encompassing greater
than two-thirds of the cervical lining thickness, including full-
thickness lesions that were formerly referred to as severe
dysplasia and carcinoma in situ.
O CIN (cervical intraepithelial neoplasia )
Mild dysplasia
Moderate dyplasia
Cervical CA.
Colposcopy
Cervical CA
Cervical lesion
Treatment
O Most women with low grade (mild) dysplasia (LGSIL, CIN1) (when
the diagnosis is confirmed and all abnormal areas have been
visualized), will undergo spontaneous regression of the mild
dysplasia without treatment. Therefore, monitoring without specific
treatment is often indicated in this group. Treatment is appropriate
for women with high-grade cervical dysplasia.
O Treatments for cervical dysplasia fall into two general categories:
destruction (ablation) of the abnormal area and removal (resection).
Both types of treatment are equally effective. Generally, destruction
(ablation) procedures are used for milder dysplasia and removal
(resection) is recommended for more severe dysplasia or cancer.
O The destruction (ablation) procedures are carbon dioxide laser
photoablation and cryocautery. The removal (resection) procedures
are loop electrosurgical excision procedure (LEEP), cold knife
conization, and hysterectomy. Treatment for dysplasia or cancer is
not usually done at the time of the initial colposcopy, since the
treatment depends on the analysis of the biopsies done during
colposcopy.
Carbon dioxide laser
photoablation
O This procedure, which is also known as CO2 laser,
uses an invisible beam of infrared light to
essentially vaporize the abnormal area. A local
anesthetic is given to numb the area prior to the
laser treatment. A substantial amount of clear
vaginal discharge and spotting of blood can occur
for a few weeks after the procedure. The
complication rate of this procedure is very low,
about 1%. The most common complications are
narrowing (stenosis) of the cervical opening and
delayed bleeding. Disadvantages of this treatment
include that this procedure does not allow
sampling of the abnormal area and is not
satisfactory for treating cervical cancer. It is useful,
however, for milder dysplasia
Cryocautery
O Like the laser treatment, cryocautery is an ablation therapy.
It uses nitrous oxide to freeze the abnormal area. This
technique, however, is not optimal for large areas or areas
where abnormalities are already advanced or severe. After
the procedure, women may experience a significant watery
vaginal discharge for several weeks. As with laser ablation,
significant complications of this procedure are rare and
occur in about 1% of patients. They include narrowing
(stenosis) of the cervix and delayed bleeding. Cryocautery
also does not allow sampling of the abnormal area and is
generally felt to be inappropriate for women with advanced
cervical disease. Thus, this procedure is not satisfactory for
treating cervical cancer, but is useful for milder dysplasia.
Cryocautery
Loop electrosurgical excision
procedure
O Loop electrosurgical excision procedure, also
known as LEEP, is an inexpensive, simple
technique that uses a radio-frequency current
to remove abnormal areas. It has an
advantage over the destructive techniques in
that an intact tissue sample for analysis can
be obtained. Vaginal discharge and spotting
commonly occur after this procedure.
Complications occur in about 1% to 2% of
women undergoing LEEP, and include
cervical narrowing (stenosis) and bleeding.
This procedure is used most commonly for
treating dysplasia, including severe dysplasia.
LEEP
Cold knife cone biopsy
(conization)
O Cone biopsy (conization) was once the primary
procedure used to treat cervical dysplasia, but the
other methods have now replaced it for this
purpose. However, when a physician cannot view
the entire area that needs to be seen during
colposcopy, a cone biopsy is typically
recommended. It is also recommended if
additional tissue sampling is needed to obtain
more information regarding the diagnosis. This
technique allows the size and shape of the
sampling to be tailored. Cone biopsy has a slightly
higher risk of cervical complications than the other
treatments, and these can include postoperative
bleeding in 5% of women and narrowing of the
cervix.
Cold knife cone biopsy
(conization)
Hysterectomy
O Hysterectomy is the surgical removal of
the uterus. This operation is used to treat
virtually all cases of invasive cervical
cancer. Sometimes, a hysterectomy is
done to treat severe dysplasia. It may also
be used if dysplasia recurs after any of the
other treatment procedures
Hysterectomy
Prognosis
O Low-grade cervical dysplasia (LGSIL and/or CIN1)
often spontaneously resolves without treatment,
but careful monitoring and follow-up testing is
required. Both ablation and resection of areas of
cervical dysplasia cure approximately 90% of
women with dysplasia, meaning that 10% of
women will have a recurrence of their abnormality
after treatment, requiring additional treatment.
When untreated, high grade cervical dysplasia
may progress to cervical cancer over time.
Resection and ablation therapies have been
shown to reduce the risk of developing cervical
cancer by 95% in the first eight years after
treatment in women with high grade dysplasia.
prevention
O A vaccine is available against four common HPV types associated with the
development of dysplasia and cervical cancer. This vaccine (Gardasil) has
received FDA approval for use in women between 9 and 26 years of age and
confers immunity against HPV types 6, 11, 16 and 18.
O Abstinence from sexual activity can prevent the spread of HPVs that are
transmitted via sexual contact. However, some researchers believe that HPV
infection might be transmitted from the mother to infant in the birth canal,
since some studies have identified genital HPV infection in populations of
young children and cloistered nuns. Hand-genital and oral-genital
transmission of HPV has also been documented and is another means of
transmission.
O HPV is transmitted by direct genital contact. The virus is not found in or
spread by bodily fluids, and HPV is not found in blood or organs harvested for
transplantation. Condom use seems to decrease the risk of transmission of
HPV during sexual activity but does not completely prevent HPV infection.
Spermicides and hormonal birth control methods do not prevent the spread of
HPV infection.
CASE :
The patient said that she had abnormal Pap
tests, dysplasia and cancer
.she was 24 years when she received a post
card in the mail saying she needed to call the
office, They did a repeat PAP test that came
back as Class 3 dysplasia, then she had a D&C.
They decided to follow it for a few months. Then
she married and have 2 babies
What is the possible treatment for her now ?
Hysterectomy
Cervical dysplasia

More Related Content

What's hot

Benign Cervical Lesions
Benign Cervical LesionsBenign Cervical Lesions
Benign Cervical LesionsEsraa Alnabilsy
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaAboubakr Elnashar
 
CIN, pap smear, colposcopy.pptx
CIN, pap smear, colposcopy.pptxCIN, pap smear, colposcopy.pptx
CIN, pap smear, colposcopy.pptxAhmed Nasef
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinomameducationdotnet
 
Colposcopy examination
Colposcopy examinationColposcopy examination
Colposcopy examinationArchana Rajendran
 
An overview of cin
An overview of cinAn overview of cin
An overview of cindr.hafsa asim
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasiaazfarneyaz
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasiadr.hafsa asim
 
Endometrial polyps
Endometrial polypsEndometrial polyps
Endometrial polypsraj kumar
 
Cancer cervix screening
Cancer cervix screeningCancer cervix screening
Cancer cervix screeningAmir Mahmoud
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasiaOsama Warda
 
Abnormal uterine bleeding
Abnormal  uterine bleedingAbnormal  uterine bleeding
Abnormal uterine bleedingAboubakr Elnashar
 
gestational trophoblastic disease GTD
gestational trophoblastic disease GTDgestational trophoblastic disease GTD
gestational trophoblastic disease GTDOsama Warda
 

What's hot (20)

Benign Cervical Lesions
Benign Cervical LesionsBenign Cervical Lesions
Benign Cervical Lesions
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
Cervical intra epithelial neoplasia
Cervical intra epithelial neoplasiaCervical intra epithelial neoplasia
Cervical intra epithelial neoplasia
 
CIN, pap smear, colposcopy.pptx
CIN, pap smear, colposcopy.pptxCIN, pap smear, colposcopy.pptx
CIN, pap smear, colposcopy.pptx
 
Endometrial Carcinoma
Endometrial CarcinomaEndometrial Carcinoma
Endometrial Carcinoma
 
Colposcopy examination
Colposcopy examinationColposcopy examination
Colposcopy examination
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Hysteroscopy
HysteroscopyHysteroscopy
Hysteroscopy
 
An overview of cin
An overview of cinAn overview of cin
An overview of cin
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
 
Endometrial polyps
Endometrial polypsEndometrial polyps
Endometrial polyps
 
Benign lesions of cervix
Benign lesions of cervixBenign lesions of cervix
Benign lesions of cervix
 
Cancer cervix screening
Cancer cervix screeningCancer cervix screening
Cancer cervix screening
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Endometrial hyperplasia
Endometrial hyperplasiaEndometrial hyperplasia
Endometrial hyperplasia
 
Abnormal uterine bleeding
Abnormal  uterine bleedingAbnormal  uterine bleeding
Abnormal uterine bleeding
 
Adnexal Masses
Adnexal  MassesAdnexal  Masses
Adnexal Masses
 
gestational trophoblastic disease GTD
gestational trophoblastic disease GTDgestational trophoblastic disease GTD
gestational trophoblastic disease GTD
 
Asherman syndrome
Asherman syndromeAsherman syndrome
Asherman syndrome
 

Viewers also liked

Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancerlok kathayat
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasiadrmcbansal
 
Cevical intraepithelial neoplasia
Cevical intraepithelial neoplasiaCevical intraepithelial neoplasia
Cevical intraepithelial neoplasiaWhitney Joseph
 
Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer pptManali Solanki
 
Dysplasia by dr manzoor n
Dysplasia by dr manzoor nDysplasia by dr manzoor n
Dysplasia by dr manzoor nMohammad Manzoor
 
Cervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsCervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsMedWorld India
 
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Doctor Faris Alabeedi
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentationrinki singh
 
Breast Cancer
Breast CancerBreast Cancer
Breast CancerFarazaJaved
 
Como Se Titula 27
Como Se Titula 27Como Se Titula 27
Como Se Titula 27TRIUMARIO
 
Hyderabad Trip
Hyderabad TripHyderabad Trip
Hyderabad Tripca.amitrathi
 
Imagenesdenuestrainfancia
ImagenesdenuestrainfanciaImagenesdenuestrainfancia
Imagenesdenuestrainfanciaguest084300
 
Cytopathology Conference 10/20/05 - Case 1
Cytopathology Conference 10/20/05 - Case 1 Cytopathology Conference 10/20/05 - Case 1
Cytopathology Conference 10/20/05 - Case 1 tmhsweb
 
Slide Share
Slide ShareSlide Share
Slide Sharehesstr
 
3 prof walter colposcopic
3  prof walter colposcopic3  prof walter colposcopic
3 prof walter colposcopicTariq Mohammed
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Lifecare Centre
 
Laser scanning cytometry and liquid based cytology
Laser scanning cytometry and liquid based cytologyLaser scanning cytometry and liquid based cytology
Laser scanning cytometry and liquid based cytologyanaonline
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical ScreeningPro Faather
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)hussamdr
 

Viewers also liked (20)

Presentation on cervical cancer
Presentation on cervical cancerPresentation on cervical cancer
Presentation on cervical cancer
 
Cervical intraepithelial neoplasia
Cervical intraepithelial neoplasiaCervical intraepithelial neoplasia
Cervical intraepithelial neoplasia
 
Cevical intraepithelial neoplasia
Cevical intraepithelial neoplasiaCevical intraepithelial neoplasia
Cevical intraepithelial neoplasia
 
Cervical cancer ppt
Cervical cancer pptCervical cancer ppt
Cervical cancer ppt
 
Dysplasia by dr manzoor n
Dysplasia by dr manzoor nDysplasia by dr manzoor n
Dysplasia by dr manzoor n
 
Cervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, TreatmentsCervical Cancer Symptoms, Causes, Treatments
Cervical Cancer Symptoms, Causes, Treatments
 
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
Premalignant lesion (Doctor Faris Alabeedi MSc, MMedSc, PgDip, BDS.)
 
Cervical Cancer Educational Presentation
Cervical Cancer Educational PresentationCervical Cancer Educational Presentation
Cervical Cancer Educational Presentation
 
Breast Cancer
Breast CancerBreast Cancer
Breast Cancer
 
Como Se Titula 27
Como Se Titula 27Como Se Titula 27
Como Se Titula 27
 
Hyderabad Trip
Hyderabad TripHyderabad Trip
Hyderabad Trip
 
Imagenesdenuestrainfancia
ImagenesdenuestrainfanciaImagenesdenuestrainfancia
Imagenesdenuestrainfancia
 
Cytopathology Conference 10/20/05 - Case 1
Cytopathology Conference 10/20/05 - Case 1 Cytopathology Conference 10/20/05 - Case 1
Cytopathology Conference 10/20/05 - Case 1
 
Slide Share
Slide ShareSlide Share
Slide Share
 
Cervical ca
Cervical caCervical ca
Cervical ca
 
3 prof walter colposcopic
3  prof walter colposcopic3  prof walter colposcopic
3 prof walter colposcopic
 
Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013Cervical cancer screening guidelines 2013
Cervical cancer screening guidelines 2013
 
Laser scanning cytometry and liquid based cytology
Laser scanning cytometry and liquid based cytologyLaser scanning cytometry and liquid based cytology
Laser scanning cytometry and liquid based cytology
 
CIN and Cervical Screening
CIN and Cervical ScreeningCIN and Cervical Screening
CIN and Cervical Screening
 
Informational macromolecules (2)
Informational macromolecules (2)Informational macromolecules (2)
Informational macromolecules (2)
 

Similar to Cervical dysplasia

CERVICAL CANCER.ppt
CERVICAL CANCER.pptCERVICAL CANCER.ppt
CERVICAL CANCER.pptFeniksRetails
 
Management of ovarian masses e Clinical situations & recommendations
Management of ovarian masses e Clinical situations & recommendations Management of ovarian masses e Clinical situations & recommendations
Management of ovarian masses e Clinical situations & recommendations Apollo Hospitals
 
Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancerDr Sachin Prakash
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancerAACHINMAYIR
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometriumsaeed456456
 
preinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise toolpreinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise toolmahadevbpatil
 
Manegement of adenexal masses in pregnancy
Manegement of adenexal masses in pregnancyManegement of adenexal masses in pregnancy
Manegement of adenexal masses in pregnancyWafaa Benjamin
 
Breast pathology
Breast pathologyBreast pathology
Breast pathologyLih Yin Chong
 
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...Lifecare Centre
 
Premalignant diseases of the cervix
Premalignant diseases of the cervixPremalignant diseases of the cervix
Premalignant diseases of the cervixmaryfaqiry
 

Similar to Cervical dysplasia (20)

Gynecology 5th year, 10th lecture (Dr. Hanaa)
Gynecology 5th year, 10th lecture (Dr. Hanaa)Gynecology 5th year, 10th lecture (Dr. Hanaa)
Gynecology 5th year, 10th lecture (Dr. Hanaa)
 
Gynecology 5th year, 9th lecture (Dr. Hanaa)
Gynecology 5th year, 9th lecture (Dr. Hanaa)Gynecology 5th year, 9th lecture (Dr. Hanaa)
Gynecology 5th year, 9th lecture (Dr. Hanaa)
 
CERVICAL CANCER.ppt
CERVICAL CANCER.pptCERVICAL CANCER.ppt
CERVICAL CANCER.ppt
 
Gyne.ppt
Gyne.pptGyne.ppt
Gyne.ppt
 
Management of ovarian masses e Clinical situations & recommendations
Management of ovarian masses e Clinical situations & recommendations Management of ovarian masses e Clinical situations & recommendations
Management of ovarian masses e Clinical situations & recommendations
 
Chemotherapy of breast cancer
Chemotherapy of breast cancerChemotherapy of breast cancer
Chemotherapy of breast cancer
 
Laparoscopic Ovarian Surgery
Laparoscopic Ovarian SurgeryLaparoscopic Ovarian Surgery
Laparoscopic Ovarian Surgery
 
Cervical cancer
Cervical cancerCervical cancer
Cervical cancer
 
Endometrium part 1 2018
Endometrium part 1 2018Endometrium part 1 2018
Endometrium part 1 2018
 
Chapter i
Chapter iChapter i
Chapter i
 
Ca endometrium
Ca endometriumCa endometrium
Ca endometrium
 
preinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise toolpreinvasive lesion of cervix and management ,quick revise tool
preinvasive lesion of cervix and management ,quick revise tool
 
CERVICAL CANCER
CERVICAL CANCERCERVICAL CANCER
CERVICAL CANCER
 
Breast cancer
Breast cancerBreast cancer
Breast cancer
 
CA Cervix
CA CervixCA Cervix
CA Cervix
 
Manegement of adenexal masses in pregnancy
Manegement of adenexal masses in pregnancyManegement of adenexal masses in pregnancy
Manegement of adenexal masses in pregnancy
 
tortion.pptx
tortion.pptxtortion.pptx
tortion.pptx
 
Breast pathology
Breast pathologyBreast pathology
Breast pathology
 
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...Asccp management guidelines august 2014 ppt.  Dr. Sharda Jain /Dr Jyoti Agarw...
Asccp management guidelines august 2014 ppt. Dr. Sharda Jain /Dr Jyoti Agarw...
 
Premalignant diseases of the cervix
Premalignant diseases of the cervixPremalignant diseases of the cervix
Premalignant diseases of the cervix
 

Recently uploaded

Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...Pooja Nehwal
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajanpragatimahajan3
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAssociation for Project Management
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingTechSoup
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 

Recently uploaded (20)

Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...Russian Call Girls in Andheri Airport Mumbai WhatsApp  9167673311 💞 Full Nigh...
Russian Call Girls in Andheri Airport Mumbai WhatsApp 9167673311 💞 Full Nigh...
 
social pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajansocial pharmacy d-pharm 1st year by Pragati K. Mahajan
social pharmacy d-pharm 1st year by Pragati K. Mahajan
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
APM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across SectorsAPM Welcome, APM North West Network Conference, Synergies Across Sectors
APM Welcome, APM North West Network Conference, Synergies Across Sectors
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 

Cervical dysplasia

  • 2. Definition O Cervical dysplasia refers to the presence of precancerous changes of the cells that make up the inner lining of the cervix, the opening to the womb (uterus). O The term dysplasia refers to the abnormal appearance of the cells when viewed under the microscope. The degree and extent of abnormality seen on a tissue sample (such as a Pap smear) was formerly referred to as mild, moderate, or severe dysplasia.
  • 3. The 2 new systems for studying the cervical dysplasia :. O (cytological system ): Squamous intraepithelial lesion is the pathology terminology for cervical dysplasia observed in smears of cells taken from the cervix. Squamous refers to the type of cell that lines the cervix. intraepithelial refers to the fact that these cells are present in the lining tissue of the cervix. O (histological system ): Cervical intraepithelial neoplasia is cervical dysplasia that is observed on a cervical biopsy or surgically removed cervix.
  • 5. The causes : O Cervical dysplasia is caused by infection of the cervix with the human papillomavirus (HPV). Although there are over 100 HPV types, a subgroup of HPVs have been found to infect the lining cells of the genital and reproductive tract in women. HPV is a very common infection and is transmitted through sexual contact; , it is possible to become re-infected with a different HPV type. O Factors that may influence persistence of the infection include: O advancing age, O duration of the infection, being infected with a "high- risk" HPV type).
  • 6. O Among the HPVs that infect the genital tract, certain types typically cause warts or mild dysplasia ("low-risk" types; HPV-6, HPV-11), while other types (known as "high-risk" HPV types) are more strongly associated with severe dysplasia and cervical cancer (HPV- 16, HPV-18). Cigarette smoking and suppression of the immune system (such as with concurrent HIV infection) have been shown to increase the risk for HPV-induced dysplasia and cancer of the cervix. O The HPV types that cause cervical cancer also have been linked with both anal and penile cancer in men as well as a subgroup of head and neck cancers in both women and men.
  • 7.
  • 8. Risk factor : O In women, an increased risk of a persistent HPV infection is associated with: O Early initiation of sexual activity. O Having multiple sex partners. O Having a partner who has had multiple sex partners. O Having sex with an uncircumcised man.
  • 9. Signs or symptoms : O Typically, cervical dysplasia does not produce any signs or symptoms. So regular screening is important for early diagnosis and treatmen
  • 10. Diagnosis O Because a pelvic exam is usually normal in women with cervical dysplasia, a Pap test is necessary to diagnose the condition. O Although a Pap test alone can identify mild, moderate, or severe cervical dysplasia, further tests are often required to determine appropriate follow-up and treatment. These include: O Repeat Pap tests. O Colposcopy, a magnified exam of the cervix to detect abnormal cells so that biopsies can be taken. O Endocervical curettage, a procedure to check for abnormal cells in the cervical canal. O Cone biopsy or loop electrosurgical excision procedure (LEEP), which are performed to rule out invasive cancer. During a cone biopsy, the doctor removes a cone-shaped piece of tissue for lab examination. During LEEP, the doctor cuts out abnormal tissue with a thin, low-voltage electrified wire loop. O HPV DNA test, which can identify the HPV strains which are known to cause cervical cancer.
  • 11.
  • 12.
  • 13.
  • 14. Classification / cytologic O Cytological analysis : by pap smear O ASC-US: This abbreviation stands for atypical squamous cells of undetermined significance. The word "squamous" describes the thin, flat cells that lie on the surface of the cervix. One of two choices are added at the end of ASC: ASC-US, which means undetermined significance, or ASC-H, which means cannot exclude HSIL . O LSIL: This abbreviation stands for low-grade squamous intraepithelial lesion. This means changes characteristic of mild dysplasia are observed in the cervical cells. O HSIL: This abbreviation stands for high-grade squamous intraepithelial lesion. And refers to the fact that cells with a severe degree of dysplasia are seen.
  • 15. Classification / histological O Histologic analysis (cervical biopsies): O CIN 1 refers to the presence of dysplasia confined to the basal third of the cervical lining, or epithelium (formerly called mild dysplasia). This is considered to be a low-grade lesion. O CIN 2 is considered to be a high-grade lesion. It refers to dysplastic cellular changes confined to the basal two-thirds of the lining tissue (formerly called moderate dysplasia). O CIN 3 is also a high grade lesion. It refers to precancerous changes in the cells encompassing greater than two-thirds of the cervical lining thickness, including full- thickness lesions that were formerly referred to as severe dysplasia and carcinoma in situ. O CIN (cervical intraepithelial neoplasia )
  • 16.
  • 20.
  • 24. Treatment O Most women with low grade (mild) dysplasia (LGSIL, CIN1) (when the diagnosis is confirmed and all abnormal areas have been visualized), will undergo spontaneous regression of the mild dysplasia without treatment. Therefore, monitoring without specific treatment is often indicated in this group. Treatment is appropriate for women with high-grade cervical dysplasia. O Treatments for cervical dysplasia fall into two general categories: destruction (ablation) of the abnormal area and removal (resection). Both types of treatment are equally effective. Generally, destruction (ablation) procedures are used for milder dysplasia and removal (resection) is recommended for more severe dysplasia or cancer. O The destruction (ablation) procedures are carbon dioxide laser photoablation and cryocautery. The removal (resection) procedures are loop electrosurgical excision procedure (LEEP), cold knife conization, and hysterectomy. Treatment for dysplasia or cancer is not usually done at the time of the initial colposcopy, since the treatment depends on the analysis of the biopsies done during colposcopy.
  • 25. Carbon dioxide laser photoablation O This procedure, which is also known as CO2 laser, uses an invisible beam of infrared light to essentially vaporize the abnormal area. A local anesthetic is given to numb the area prior to the laser treatment. A substantial amount of clear vaginal discharge and spotting of blood can occur for a few weeks after the procedure. The complication rate of this procedure is very low, about 1%. The most common complications are narrowing (stenosis) of the cervical opening and delayed bleeding. Disadvantages of this treatment include that this procedure does not allow sampling of the abnormal area and is not satisfactory for treating cervical cancer. It is useful, however, for milder dysplasia
  • 26.
  • 27. Cryocautery O Like the laser treatment, cryocautery is an ablation therapy. It uses nitrous oxide to freeze the abnormal area. This technique, however, is not optimal for large areas or areas where abnormalities are already advanced or severe. After the procedure, women may experience a significant watery vaginal discharge for several weeks. As with laser ablation, significant complications of this procedure are rare and occur in about 1% of patients. They include narrowing (stenosis) of the cervix and delayed bleeding. Cryocautery also does not allow sampling of the abnormal area and is generally felt to be inappropriate for women with advanced cervical disease. Thus, this procedure is not satisfactory for treating cervical cancer, but is useful for milder dysplasia.
  • 29. Loop electrosurgical excision procedure O Loop electrosurgical excision procedure, also known as LEEP, is an inexpensive, simple technique that uses a radio-frequency current to remove abnormal areas. It has an advantage over the destructive techniques in that an intact tissue sample for analysis can be obtained. Vaginal discharge and spotting commonly occur after this procedure. Complications occur in about 1% to 2% of women undergoing LEEP, and include cervical narrowing (stenosis) and bleeding. This procedure is used most commonly for treating dysplasia, including severe dysplasia.
  • 30. LEEP
  • 31. Cold knife cone biopsy (conization) O Cone biopsy (conization) was once the primary procedure used to treat cervical dysplasia, but the other methods have now replaced it for this purpose. However, when a physician cannot view the entire area that needs to be seen during colposcopy, a cone biopsy is typically recommended. It is also recommended if additional tissue sampling is needed to obtain more information regarding the diagnosis. This technique allows the size and shape of the sampling to be tailored. Cone biopsy has a slightly higher risk of cervical complications than the other treatments, and these can include postoperative bleeding in 5% of women and narrowing of the cervix.
  • 32. Cold knife cone biopsy (conization)
  • 33. Hysterectomy O Hysterectomy is the surgical removal of the uterus. This operation is used to treat virtually all cases of invasive cervical cancer. Sometimes, a hysterectomy is done to treat severe dysplasia. It may also be used if dysplasia recurs after any of the other treatment procedures
  • 35. Prognosis O Low-grade cervical dysplasia (LGSIL and/or CIN1) often spontaneously resolves without treatment, but careful monitoring and follow-up testing is required. Both ablation and resection of areas of cervical dysplasia cure approximately 90% of women with dysplasia, meaning that 10% of women will have a recurrence of their abnormality after treatment, requiring additional treatment. When untreated, high grade cervical dysplasia may progress to cervical cancer over time. Resection and ablation therapies have been shown to reduce the risk of developing cervical cancer by 95% in the first eight years after treatment in women with high grade dysplasia.
  • 36. prevention O A vaccine is available against four common HPV types associated with the development of dysplasia and cervical cancer. This vaccine (Gardasil) has received FDA approval for use in women between 9 and 26 years of age and confers immunity against HPV types 6, 11, 16 and 18. O Abstinence from sexual activity can prevent the spread of HPVs that are transmitted via sexual contact. However, some researchers believe that HPV infection might be transmitted from the mother to infant in the birth canal, since some studies have identified genital HPV infection in populations of young children and cloistered nuns. Hand-genital and oral-genital transmission of HPV has also been documented and is another means of transmission. O HPV is transmitted by direct genital contact. The virus is not found in or spread by bodily fluids, and HPV is not found in blood or organs harvested for transplantation. Condom use seems to decrease the risk of transmission of HPV during sexual activity but does not completely prevent HPV infection. Spermicides and hormonal birth control methods do not prevent the spread of HPV infection.
  • 37. CASE : The patient said that she had abnormal Pap tests, dysplasia and cancer .she was 24 years when she received a post card in the mail saying she needed to call the office, They did a repeat PAP test that came back as Class 3 dysplasia, then she had a D&C. They decided to follow it for a few months. Then she married and have 2 babies What is the possible treatment for her now ? Hysterectomy